Such barriers are particularly pronounced in the US, where Congress oversees the legal framework within which federal regulatory agencies – such as the Environmental Protection Agency and the Food and Drug Administration – operate. Not only do the US administration and its federal agencies have to accept that a safety standard established and tested in Frankfurt or Athens is equivalent to its US counterpart; congressional committees must agree.